Smith & Nephew strengthens global sports medicine business through agreement to acquire ArthroCare for $1.7 billion

29 May 2014

Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, today announces the completion of the acquisition of ArthroCare Corporation, an innovative medical device company with a highly complementary sports medicine portfolio. The purchase price was $48.25 per share paid in cash, translating into an enterprise value of approximately $1.5 billion.

 

Enquiries

Investors
Phil Cowdy
Smith & Nephew 
+44 (0) 20 7401 7646


Financial Media
Charles Reynolds
Smith & Nephew 
+44 (0) 20 7401 7646


Andrew Mitchell / Justine McIlroy
Brunswick 
+44 (0) 20 7404 5959


Trade Media
Joe Metzger
Smith & Nephew Advanced Surgical Devices 
+1 (978) 273 5187

 

Visit the ArthroCare Corp. website and find out more about ArthroCare Coblation® technology

 

® Trademark of ArthroCare Corp.

 

Smith & Nephew is a global medical technology business dedicated to helping improve people's lives.

 

With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith & Nephew has almost 11,000 employees and a presence in more than 90 countries.